Delays in Neovasc’s (NSDQ:NVCN) early feasibility trial for its Tiara transcatheter mitral valve implant and declining 1st-quarter profits combined to push its stock price down this week.
Cardiovascular
Welcome to MassDevice's Cardiovascular Hub, your resource for the latest news in cardiac implants, structural heart, heart valves, stents and more. Stay informed about the innovations and business news shaping the cardiovascular device industry.
🫀 Narrow your focus with these categories:
Cardiac Implants | Structural Heart | Pulsed-Field Ablation
Here are top cardiology features from MassDevice and its sister publications (and scroll down to read the latest cardiology device news from MassDevice):
+ LVADs save lives: So why aren’t more available?
+ How Medtronic uses nitinol to improve the structure and effectiveness of heart devices
+ How Abbott designed the world’s first dual-chamber leadless pacemaker system
+ J&J used RWE for expanded indications — and you can, too
+ 7 cardiology startups you need to know
Latest Cardiology News
HRS 2015: Study shows Abbott’s MitraClip halves arrhythmias
HRS 2015: Boston Scientific touts cost-saving data for Watchman
HRS 2015: SentreHeart’s Lariat device leads to 20% leak rate
Biotronik looks to get into the TAVI game
Biotronik today said its entry into a hot replacement heart valve market passed the safety endpoint of a 1st-in-human trial.
The German medical device giant said the Biovalve trial of its transcatheter aortic valve implant established the device’s early safety at 30 days.
Medtronic launches in-office study of Reveal Linq heart monitor
Sorin hopes Perceval valve will rescue flat results
FDA clears Medtronic’s Euphora balloon
TAVI: U.K. study finds 60% survival rate at 3 years
Surprise CE Mark for Stentys Xposition S stent
Stentys this week said it won a CE Mark ahead of schedule for its latest self-apposing coronary stent, a product that will be used with delivery system technology it acquired last June.